Treatment response and long term follow up in nineteen dogs diagnosed with chronic enteropathy in Australia

• Published in: Australian veterinary journal 2019-09, Vol.97 (9), p.301-307
• Main Authors: Dandrieux, JRS, Martinez Lopez, LM, Prakash, N, Mansfield, CS
• Format: Article
• Language: English
• Subjects: Animals; Anti-Bacterial Agents - therapeutic use; antibiotic; Antibiotic resistance; Antibiotics; Australia; Chronic Disease; chronic enteropathy; Clinical trials; Cohort Studies; Diet; dog; Dog Diseases - diagnosis; Dog Diseases - diet therapy; Dog Diseases - drug therapy; Dogs; Female; Gastrointestinal Diseases - diagnosis; Gastrointestinal Diseases - diet therapy; Gastrointestinal Diseases - drug therapy; Gastrointestinal Diseases - veterinary; Immunosuppressive agents; inflammatory bowel disease; Inflammatory Bowel Diseases - veterinary; Male; Prospective Studies; Remission; treatment; Treatment Outcome; Victoria
• ISSN: 0005-0423; 1751-0813
• DOI: 10.1111/avj.12846

Chronic enteropathy (CE) in dogs is common worldwide, but little data is available from Australia. The aim of this study was to describe treatment response and long‐term outcome in a cohort of dogs with CE. Dogs were prospectively enrolled at Murdoch University and the University of Melbourne. After diagnostic investigation to rule out diseases other than CE, dogs underwent sequential therapeutic trials until achieving a clinical response (diet then antibiotics, and finally immunosuppressants). Success was defined as 75% reduction of clinical severity for a minimum of five weeks. A total of 21 dogs were enrolled, and 19 completed the study. One dog was euthanised for lack of response to treatment and one excluded for lack of owner compliance. Most dogs responded to diet (n = 10), followed by antibiotics (n = 7) and immunosuppressants (n = 2). Long‐term remission (median 21.1 months, [3.0‐44.7]) was achieved in eight out of ten dietary responders without additional treatment. In contrast, only two dogs with antibiotic response remained in long‐term remission, of which one needed on‐going antibiotic treatment. Longer term remission was achieved in the two dogs treated with immunosuppressants with on‐going low dose therapy. This study concludes that most dogs referred for CE in Australia respond to dietary treatment (even after previous dietary interventions), and remission is long‐term compared to dogs treated with an antibiotic. Furthermore, the need for long‐term antibiotics in some dogs to maintain response may lead to antibiotic resistance. This study supports adequate dietary trials for CE in dogs, and a need for alternative second‐line treatments.